• No results found

(5)Locally advanced rectal cancer New insights for a tailored approach Proefschrift Ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr

N/A
N/A
Protected

Academic year: 2021

Share "(5)Locally advanced rectal cancer New insights for a tailored approach Proefschrift Ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr"

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/136093 holds various files of this Leiden University dissertation.

Author: Valk, M.J.M. van der

Title: Locally advanced rectal cancer: New insights for a tailored approach Issue date: 2020-09-03

(2)
(3)

Locally advanced rectal cancer New insights for a tailored approach

Maxime Johanna Maria van der Valk

(4)

through the Bas Mulder award granted to Dr. Denise Hilling

Financial support for printing of this thesis by Erbe, Quest Medical Imaging and Chipsoft is gratefully acknowledged.

(5)

Locally advanced rectal cancer New insights for a tailored approach

Proefschrift

Ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op donderdag 3 september 2020

klokke 13.45 uur

door

Maxime Johanna Maria van der Valk geboren te Nijmegen

in 1988

(6)

Co-promotor Dr. D.E. Hilling Promotiecommissie Prof. dr. H. Putter Prof. dr. C.A.M. Marijnen

Prof. dr. H. Rutten Maastricht Universitair Medisch centrum, Catharina ziekenhuis Prof. dr. G.A.P. Hospers Universitair Medisch Centrum Groningen

Dr. J. Melenhorst Maastricht Universitair Medisch centrum

(7)

CONTENTS

Chapter 1 Introduction and thesis outline

Chapter 2 Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicenter registry study

Chapter 3 Quality of life after curative resection for rectal cancer in patients treated with adjuvant chemotherapy compared with observation:

results of the randomized phase III SCRIPT trial

Chapter 4 Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer:

results of the international randomized RAPIDO-trial

Chapter 5 Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clini- cians know what patients want?

Chapter 6 Disqualification of the Neoadjuvant Rectal (NAR) score based on data of 6596 from the Netherlands Cancer Registry

Chapter 7 Summary and general discussion

Appendix Nederlandse samenvatting Publicatielijst

Curriculum vitae Dankwoord

7 21

45

65

91

109

123

141 155 153 149

(8)

Referenties

GERELATEERDE DOCUMENTEN

Title: Locally advanced rectal cancer: New insights for a tailored approach Issue date: 2020-09-03... V AN D ER V

29, 30 For rectal cancer patients with a high risk of local recurrence, multiple randomized trials have been performed, but a survival benefit for the use of

The pres- ent study aims to assess the patient-reported HR-QOL of patients with rectal cancer in the first year after curative surgery treated with 6 months of adjuvant

High- risk rectal cancer patients were randomized to SCRT followed by chemotherapy (6 cycles CA- POX or alternatively 9 cycles FOLFOX4) and subsequent surgery, or

This study shows no additional value for using the NAR formula as a surrogate endpoint for overall survival in rectal cancer patients treated with neoadjuvant therapy.... Chapter

Subsequently, to estimate the risk of simultaneous damage to the LAN in case of damage to the pelvic splanchnic nerves, faecal and urinary incontinence were related to difficulty

16 Therefore, patients with early rectal cancer after neoadjuvant treatment (ypT1 and ypT2) might be considered candidates for local excision by means of transanal endoscopic

Urinary dysfunction (UD) after rectal cancer treatment is a common problem, of which the contributing factors are unclear. To evaluate UD during five years after TME and to